Clinical Trial Packaging Market Size, Share, Growth, Forecast 2032

Clinical Trial Packaging Market Insights

Zion Market Research has published a report on the global Clinical Trial Packaging Market, estimating its value at USD 3.63 Billion in 2023, with projections indicating that it will reach USD 12.98 Billion by 2032. The market is expected to expand at a compound annual growth rate (CAGR) of 15.2% over the forecast period 2024-2032.

The report explores the factors fueling market growth, the hitches that could hamper this expansion, and the opportunities that may arise in the Clinical Trial Packaging Market industry. Additionally, it offers a detailed analysis of how these elements will affect market demand dynamics and market performance throughout the forecast period.

Request Free Sample

Global Clinical Trial Packaging Market: Overview

Clinical trial packaging is solely for research purposes and one can never find them in retail stores. These packaging consists of two types that are primary and secondary and both are used for separate purposes. Primary packaging comprises multi-dose blistering and bottling with solid dose capabilities. Contrarily, secondary packaging comprises labeling, translational services, artwork design, label printing, patient kit assembly, and randomization. Packaging also holds prime importance to get the drug ready for a clinical trial.

The global market for clinical trial packaging has grown significantly over the past few years as a consequence of the rise in demand for clinical trial packaging. To help the industry establish a long-term solution and expand, the top producers of clinical trial packaging are investing in R&D. Through expanded distribution channels, mergers, and acquisitions, manufacturers in the clinical trial packaging industry are largely concentrating on extending their geographic reach. The growing importance of booklet labels is one of the changes in clinical trial packaging.

Request Free Sample

Global Clinical Trial Packaging Market: Growth Factors

The increasing number of clinical trials with the advent of the COVID-19 pandemic, the surge in research and development activities in biotech and pharmaceutical companies for the discovery of novel drugs, and the budding trend of outsourcing drugs to different regions and cities for clinical trials are the some of the prime factors which are propelling the growth of global clinical trial packaging market. Formerly clinical trials were primarily focused on solid-dose drugs, but currently, more injectable drugs are also being tested.

Sustainability has been one of the most often debated subjects in the packaging value chain over the past ten years as a result of shifting regulatory requirements and a growing market demand for sustainable packaging solutions. Consumer behavior and purchasing decisions are still influenced by a variety of variables, particularly in the retail sector and, to some extent, the pharmaceutical business. Given that a number of market players are leaning toward the adoption of sustainable packaging materials, it is anticipated that a growing customer preference for sustainable packaging will continue to be one of the main factors likely to influence the development of the global for clinical trial packaging over the projected period.

Clinical Trial Packaging Market: Report Scope

The biological substance drug is distinctly presented in ampoules, syringes, and vials, which needs a precise form of clinical packaging. Additionally, the regulatory authorities are emphasizing the pharmaceutical industry to test their drug on more patients. This has caused a considerable rise in the number of clinical trials.  Along, with the rise in the occurrence of chronic diseases, pharmaceutical companies are involved in processes of drug discovery, and to qualify the regulatory requirements they are outsourcing their drugs to contract research organizations in order to conduct clinical trials on large scale. There is also an increase in the number of developments of vaccines and biosimilars. All these factors are jointly contributing to the global market growth at a significant rate.

Furthermore, the concept of blinding consists of double and triple blinding which is vital in clinical trials, and requires appropriate labeling is driving the growth of the global market. Moreover, huge investments are made by pharmaceutical companies for the drug discovery program, which is expected to create numerous growth opportunities for the clinical trial packaging market in the estimated timeframe. However, the unavailability of trained staff and poor healthcare infrastructure in low and middle-income countries are the factors that may hinder the growth of the global clinical trial packaging market.

Global Clinical Trial Packaging Market: Segmentation

The global clinical trial packaging market can be segmented into the packaging type, material type, end-user, and region.

By packaging type, the market can be segmented into bottles, blisters, tubes, kits or packs, sachets, vials & ampoules, syringes, and bags & pouches.

By material type, the market can be segmented into metal, glass, paper, plastic, and corrugated fiber.

By end-use, is segmented into facilities, CRO’s, and research laboratories.

Global Clinical Trial Packaging Market: Competitive Players

Some of the key players in the clinical trial packaging market are -

• PAREXEL International Corporation
• Pharmaterials Ltd
• WuXi AppTec
• Piramal Enterprises Ltd
• The Coghlan Group
• Fisher Clinical Services
• Westrock Company
• Bilcare Limited
• Almac Group Limited
• PCI Pharma Services and among others.

Global Clinical Trial Packaging Market: Regional Analysis

North America is projected to hold a significant share in the clinical trial packaging market over the projected period. Factors such as an increase in R&D activities, the presence of major players, and a large number of clinical trials in the region are notably contributing to the market growth.

Request Free Sample

Europe is also predicted to contribute a noteworthy share of the market. Owing to the increase in focus on rare diseases and the rise in the development of biosimilar drugs are attributed to contributing to the growth in the region. 

Global Clinical Trial Packaging market is segmented as follows:

By Packaging Type

• Bottles
• Blisters
• Tubes
• Kits or packs
• Sachets
• Vials & ampoules
• Syringes
• Bags & pouches

By Material Type

• Metal
• Glass
• Paper
• Plastic
• Corrugated fiber

By End User

• Facilities
• CRO’s
• Research laboratories

Global Clinical Trial Packaging Market: Regional Segment Analysis

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of The Middle East & Africa